Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
alirocumab
alnylam pharmaceuticals
amgen
biotech
boston blog main
clinical trials
evolocumab
2
×
inclisiran
life sciences
national blog main
new york
new york blog main
new york top stories
pcsk9 inhibitors
regeneron pharmaceuticals
2
×
rna interference
boston top stories
deals
drugs
evercore isi
fda
heart attack
joseph swartz
medicines co.
national top stories
novartis
pcsk9
sanofi
stroke
svb leerink
the medicines company
umer raffat
What
cholesterol
drug
medco
medicines
2
×
new
acquire
agreed
alnylam
based
billion
brings
cash
company
compound
data
deal
evidence
fda
heart
lasting
long
looms
lowering
novartis
partner
pharmaceuticals
poised
presented
ready
reckoning
rna
supporting
term
touts
use
wave
Language
unset
Current search:
evolocumab
×
photo
×
medicines
×
" regeneron pharmaceuticals "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms